Stevens-Johnson syndrome associated with concomitant use of lamotrigine and valproic acid

Journal of the American Academy of Dermatology

Volumn 43, Issue 5 SPEC. SUPPL., 2000, Pages 898-899

  Yalçin, Başak ^a   Karaduman, Ayşen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE; NEUROLEPTIC AGENT; PREDNISOLONE; VALPROIC ACID;

ADULT; ARTICLE; BLISTER; CASE REPORT; CLINICAL FEATURE; DRUG EFFECT; DRUG ERUPTION; DRUG RESPONSE; FEMALE; FEVER; HUMAN; PRIORITY JOURNAL; RASH; SKIN DEFECT; STEVENS JOHNSON SYNDROME;

EID: 0033763162     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(00)70216-7     Document Type: Article

References (14)

1. New antiepileptic drugs: A review
2. Anticonvulsants and antiepileptics in the treatment of bipolar disease
3. Pharmacologic studies on lamotrigine, a novel potential antiepileptic drug: Anticonvulsant profile in mice and rats
4. An in vitro investigation of the action of lamotrigine on neuronal voltage activated sodium channels
5. Lamotrigine
6. Lamotrigine: An antiepileptic agent for the treatment of partial seizures
7. Reactive erythemas
8. Safety review of adult clinical trial experience with lamotrigine
9. Suspected lamotrigine induced toxic epidermal necrolysis
10. Lamotrigine induced Stevens Johnson syndrome: Demonstration of specific lymphocyte reactivity in vitro
11. Rechallenge with lamotrigine after initial rash
12. Phenytoin-like hypersensitivity associated with lamotrigine
13. Fulminant hepatic failure induced by lamotrigine
14. Multiorgan failure and disseminated intravascular coagulation in severe convulsive seizures